Referring Hospitalized Smokers to Outpatient Quit Services A Randomized Trial

被引:11
|
作者
Fellows, Jeffrey L. [1 ]
Mularski, Richard A. [1 ]
Leo, Michael C. [1 ]
Bentz, Charles J. [2 ]
Waiwaiole, Lisa A. [1 ]
Francisco, Melanie C. [1 ]
Funkhouser, Kimberly [1 ]
Stoney, Catherine M. [3 ]
机构
[1] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
[2] Legacy Hlth Syst, Tobacco Cessat & Prevent, Portland, OR USA
[3] NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA
关键词
SMOKING-CESSATION INTERVENTION; SYSTEM; CARE;
D O I
10.1016/j.amepre.2016.06.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Linking outpatient cessation services to bedside counseling for hospitalized smokers can improve long-run quit rates. Adding an assisted referral (AR) offer to a tobacco treatment specialist consult service fits the team approach to care in U.S. hospitals. Design: A two-arm patient-randomized trial tested the effectiveness of adding an AR offer to outpatient smoking-cessation services and interactive voice recognition (AR+IVR) follow-up to a usual care (UC) tobacco-cessation consult for hospitalized smokers. Setting/participants: Over 24 months (November 2011-November 2013), 898 hospitalized adult smokers interested in quitting smoking were recruited from three large hospitals in the Portland, Oregon, area: an integrated group model HMO (n=622), a community hospital (n=195), and an academic health center (n=81). Intervention: Tobacco treatment specialists identified smokers and provided an intensive bedside tobacco use assessment and cessation consultation (UC). AR+IVR recipients also received proactive ARs to available outpatient counseling programs and medications, and linked patients to a tailored IVR telephone follow-up system. Main outcome measures: The primary outcome was self-reported 30-day abstinence at 6-month follow-up. Secondary outcomes included self-reported and continuous abstinence and biochemically confirmed 7-day abstinence at 6 months. Follow-up was completed in September 2014; data were analyzed in 2015. Results: A total of 597 and 301 hospitalized smokers were randomized to AR+IVR and UC, respectively. AR+IVR and UC recipients received 19.3 and 17.0 minutes of bedside counseling (p=0.372), respectively. Most (58%) AR+IVR patients accepted referrals for counseling, 43% accepted medications, and 28% accepted both. Self-reported 30-day abstinence for AR+IVR (17.9%) and UC (17.3%) were not statistically significant (p=0.569). Differences in 7-day, continuous, and biochemically confirmed abstinence by treatment group also were insignificant, overall and adjusting for site. Conclusions: Adding an AR to outpatient counseling and medications did not increase cigarette abstinence at 6 months compared to UC alone. (C) 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:609 / 619
页数:11
相关论文
共 50 条
  • [11] RESOURCE UTILIZED IN A RANDOMIZED CLINICAL TRIAL TO RECRUIT SMOKERS WITH LOW MOTIVATION TO QUIT
    Rasu, R.
    Thelen, J.
    Bawa, Agbor W.
    Goggin, K.
    Harris, K.
    Richter, K.
    Williams, K.
    Patten, C.
    Bradley-Ewing, A.
    Catley, D.
    VALUE IN HEALTH, 2014, 17 (07) : A779 - A779
  • [12] ENCOURAGING PRIMARY CARE PHYSICIANS TO HELP SMOKERS QUIT - A RANDOMIZED, CONTROLLED TRIAL
    COHEN, SJ
    STOOKEY, GK
    KATZ, BP
    DROOK, CA
    SMITH, DM
    ANNALS OF INTERNAL MEDICINE, 1989, 110 (08) : 648 - 652
  • [13] Can brain games help smokers quit?: Results of a randomized clinical trial
    Loughead, James
    Falcone, Mary
    Wileyto, E. Paul
    Albelda, Benjamin
    Audrain-McGovern, Janet
    Cao, Wen
    Kurtz, Matthew M.
    Gur, Ruben C.
    Lerman, Caryn
    DRUG AND ALCOHOL DEPENDENCE, 2016, 168 : 112 - 118
  • [14] Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial
    Hughes, John R.
    Rennard, Stephen I.
    Fingar, James R.
    Talbot, Sandy K.
    Callas, Peter W.
    Fagerstrom, Karl O.
    NICOTINE & TOBACCO RESEARCH, 2011, 13 (10) : 955 - 964
  • [15] Which hospitalized smokers receive a prescription for quit-smoking medication at discharge? A secondary analysis of a smoking cessation randomized clinical trial
    Patel, Vivek N.
    Richter, Kimber P.
    Mussulman, Laura M.
    Nazir, Niaman
    Gajewski, Byron
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (06) : 857 - 861
  • [16] Effect of Clinician Advice and Patient Preparedness to Quit on Subsequent Quit Attempts in Hospitalized Smokers
    Shah, Lisa M.
    King, Andrea C.
    Basu, Anirban
    Krishnan, Jerry A.
    Borden, William B.
    Meltzer, David
    Arora, Vineet
    JOURNAL OF HOSPITAL MEDICINE, 2010, 5 (01) : 26 - 32
  • [17] A Randomized Trial of Motivational Interviewing Cessation Induction Among Smokers With Low Desire to Quit
    Catley, Delwyn
    Goggin, Kathy
    Harris, Kari Jo
    Richter, Kimber P.
    Williams, Karen
    Patten, Christi
    Resnicow, Ken
    Ellerbeck, Edward F.
    Bradley-Ewing, Andrea
    Lee, Hyoung S.
    Moreno, Jose L.
    Grobe, James E.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 50 (05) : 573 - 583
  • [18] Planning a Change Easily (PACE): A randomized controlled trial for smokers who are not ready to quit
    Garcia, Francisco I. Salgado
    Derefinko, Karen J.
    Bursac, Zoran
    Hand, Sarah
    Klesges, Robert C.
    CONTEMPORARY CLINICAL TRIALS, 2018, 68 : 14 - 22
  • [19] Do electronic cigarettes help smokers quit? Results from a randomized controlled trial
    Bullen, Christopher
    Howe, Colin
    Laugesen, Murray
    McRobbie, Hayden
    Parag, Varsha
    Williman, Jonathan
    Walker, Natalie
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [20] Increasing treatment enrollment among smokers who are not motivated to quit: a randomized clinical trial
    Vinci, Christine
    Lam, Cho
    Schlechter, Chelsey R.
    Shono, Yusuke
    Vidrine, Jennifer, I
    Wetter, David W.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2022, 12 (01) : 121 - 128